Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Document › Details

Selexis S.A.. (10/10/16). "Press Release: Selexis SA Announces Participation at Two Upcoming Industry Conferences". Geneva.

Region Region Lisboa (Lisbon)
  Country Portugal
Organisations Organisation Selexis S.A.
  Group JSR Corporation (Group)
  Organisation 2 Sam Brown Inc.
Products Product PEGS Europe 2016 Lisboa (Lisbon)
  Product 2 BIO-Europe 2016 Köln (Cologne)
Persons Person Girod, Pierre-Alain (Selexis 201610 CSO)
  Person 2 Meister, Robert (Selexis 201511 Head Corporate + Marketing Communications)
     


Selexis SA, a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, announced today its planned participation at two industry conferences in the coming weeks, as follows:

PEGS Europe
31 October 2016 to 4 November 2016, Lisbon, Portugal
Selexis Chief Scientific Officer Pierre-Alain Girod, PhD, will present “Engineering of CHO Cell Lines for Enhanced Process Robustness,” on 2 November at 12:30 p.m. GMT. Selexis will also be sponsoring and exhibiting at the conference.
For more information, visit: http://www.pegsummiteurope.com/

BIO-Europe
7 – 9 November 2016, Cologne, Germany
Selexis will participate in the partnering program.
For more information, visit: https://ebdgroup.knect365.com/bioeurope/


About Selexis SA

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the highly specialized expertise that is necessary to translate scientific innovation into life-saving medicines for patients. Selexis’ SUREtechnology Platform™ facilitates the rapid, stable, and cost-effective production of virtually any recombinant protein and provides seamless integration of the bioproduction continuum, spanning discovery to commercialization. With more than 95 partners worldwide, nearly 80 drug products in clinical manufacturing and two commercial products utilizing its cell lines, Selexis has a history of empowering scientists and biopharmaceutical companies around the world to realize the full potential of their research. More information is available at www.selexis.com.

FOR MORE INFORMATION

– Web www.selexis.com
– LinkedIn www.linkedin.com/company/selexis-sa
– Twitter www.twitter.com/SelexisSA
– Facebook www.facebook.com/SelexisSA


Media Inquiries for Selexis

Mike Beyer
Sam Brown Inc.
+1 312-961-2502
mikebeyer@sambrown.com

Company Inquiries for Selexis

Robert Meister
Head, Corporate Communications
+1 602-953-1716
robert.meister@selexis.com

   
Record changed: 2017-07-02

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for JSR Corporation (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px




» top